Moreover, exosomal miR-452-5p directly targeted tissue inhibitors of metalloproteinases 3 (TIMP3) to induce M2 phenotype TAMs proliferation and polarization, representing a promising miR-452-5p/TIMP3 axis in HCC therapy (91). This evidence concerns the gene TIMP3 and hepatocellular carcinoma.